Partners – Pharma Sponosrs
Boehringer Ingelheim is a global, research-driven pharmaceutical company committed to improving human and animal health. As a family-owned business, BI focuses on developing innovative therapies in areas of unmet medical need, particularly in respiratory, cardiovascular, oncology, and central nervous system diseases.
Amgen is a leading biotechnology company that uses advanced science and innovation to develop therapies for serious illnesses. With a focus on areas such as oncology, nephrology, cardiology, and inflammation, Amgen leverages cutting-edge biologics and genetics to improve patient outcomes.
Novartis is a global healthcare company based in Switzerland that reimagines medicine to improve and extend people’s lives. The company focuses on innovative patented medicines and is a leader in oncology, immunology, neuroscience, and gene therapies, supported by a strong research and development pipeline.
GSK is a global biopharma company headquartered in the UK, focused on preventing and treating disease through vaccines, specialty medicines, and general pharmaceuticals. GSK prioritizes innovation in infectious diseases, oncology, and immunology, aiming to improve global health through science and technology.
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for serious diseases. BMS focuses on transformative treatments in oncology, hematology, immunology, and cardiovascular disease, with a mission to help patients prevail over serious illnesses.